2019 Healthcare Licensing Analytical Report with Focus on Transplants – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Analytical
Report for Healthcare Licensing with focus on Transplant”
report has been added to ResearchAndMarkets.com’s
offering.

Transplantation gives thousands of children and adults each year a
renewed chance at living full and active lives. 60+ licensing news with
focus on Transplant are reported and analyzed to provide a snapshot view
of the current business trends here.

Analytical data coverage:

• January 1, 2018 to March 31, 2019 licensing deals and negotiations
• 60+ worldwide Transplant focused healthcare licensing news of
  companies across North America (58%), Europe (23%), Asia (13%)
• Small-mid-large cap companies covered – LargeCap (16%), SmallCap (12%)
• Listed and non-listed companies included
• 4 healthcare sub-sectors covered – Pharmaceuticals (13%), Biotech
  (45%), Healthcare Services (26%), Medical Devices (13%)
• 14 medicine groups studied – Oncology (29%), Hematology (22%)
• 8+ variables analyzed

User benefits:

• Immediate access to current global licensing trends for Transplant
• Succinct summaries of licensing deals and negotiations held worldwide
• Quick to-the-point analytical references
• In-depth updates on wider perspective of Transplant
• Directions to the emerging business prospects

Key analysis in the report:

• Leading countries in Transplant focused licensing
• Most active healthcare sub-sectors in Transplant focused licensing
• Distribution of Transplant focused licensing deals among market cap
  groups
• Comparisons of different medicine groups in Transplant focused
  licensing
• Companies currently engaging the most in Transplant focused licensing
• Dynamics of varied licensing payments arrangements worldwide

Report useful to:

• Transplant focused healthcare companies seeking licensing opportunities
• Transplant focused healthcare companies seeking new market base
• Executives of healthcare companies negotiating licensing for Transplant
• Investors analyzing varied kinds of transaction options for Transplant
  focused licensing

Key Topics Covered

Introduction

Research Design

Chapter 1: Analysis of healthcare inventions with focus on
Transplant licensed during the past five quarters

1.1 Number of licensing deals with focus on Transplant

1.2 Countries with most licensing deals with focus on Transplant

1.3 Healthcare sub-sectors with most licensing deals with focus on
Transplant

1.4 Market capitalization groups with most licensing deals with focus on
Transplant

1.5 Medicine groups with most licensing deals with focus on Transplant

1.6 Leading companies with most licensing deals with focus on Transplant

1.7 Licensing payment arrangements most followed in licensing deals with
focus on Transplant

Chapter 2: Key licensing deals with focus on Transplant during
the past five quarters – By type of licensing deal

Chapter 3: Global healthcare inventions with focus on Transplant
licensed during the past five quarters – By region and company name

Chapter 4: Summary and conclusions

Appendices

Appendix 1 List of companies/institutes covered

a) By region, country and company name

b) By sub-industry, country and company name

c) By market capitalization group, country and company name

d) By medicine group, country and company name

e) By terms of payment, country and company name

Appendix 2 List of non-listed companies covered – By country and company
name

Appendix 3 List of not-for-profit institutes covered – By country and
institute name

Companies Mentioned

Alphabetical List of Sample 30 Companies/Institutes (of the total 101
companies covered) in the Report:

• Natera Inc.
• Neovii pharmaceuticals AG
• Neuralstem, Inc.
• Novartis AG
• Novimmune SA
• Omeros Corporation
• Omixon Ltd.
• Orbit Biomedical Ltd
• Organovo Holdings Inc.
• OrganOx Limited
• Orgenesis Inc. Biotech
• Ortho-Clinical Diagnostics, Inc.
• Paragonix Technologies, Inc
• Partner Therapeutics Inc.
• Pharmaceutics International, Inc.
• PIRCHE AG
• Pressure BioSciences Inc.
• Sana Biotechnology, Inc.
• Sanofi SA
• SATT Lutech
• SCM Lifescience Co., Ltd.
• Seattle Genetics, Inc.
• Second Genome Inc
• Seoul National University Bundang Hospital
• Sinovant Sciences Ltd
• SQI Diagnostics Inc
• Stanford Cancer Institute
• Steinbeis Centre for Biopolymer Analysis and Biomedical Mass
  Spectrometry
• Stowers Institute for Medical Research
• Swedish Orphan Biovitrum AB

For more information about this report visit https://www.researchandmarkets.com/r/qwo4ir

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Healthcare
Services